The inhibition of angiogenesis in carcinomas of nebivolol-treated mice was additionally confirmed by the reduced expression of the endothelial cell CD31 marker (Fig. 5k), the basement membrane marker laminin (Fig. 5l) and of αSMA, a marker of pericytes (Fig. 5m). This evidence concerns the gene PECAM1 and carcinoma.